Table 2.

Changes in the studied parameters before and 2 months after treatment

		Group A	Group B	Group C	P value
VAS	Before	5.63±2.02	4.93±2.34	5.70±2.11	NS
	After	1.96±1.66	1.55±1.47	3.37±1.94	<0.001*
Grip Strength	Before	21.94±4.74	22.27±4.53	23.11±3.50	NS
	After	25.38±4.47	25.94±4.26	24.60±3.33	NS
Pinch strength	Before	4.31±0.67	4.27±1.05	4.02±0.65	NS
	After	5.67±0.73	6.08±0.90	4.50±0.85	<0.001*
SSS	Before	3.50±0.43	3.65±0.33	3.48±0.56	NS
	After	2.41±0.52	2.19±0.43	2.86±0.51	<0.001*
FSS	Before	4.32±0.52	4.36±0.54	4.12±0.47	NS
	After	3.22±0.95	3.17±0.72	3.70±0.56	0.02*
BCTQ total	Before	7.83±0.87	8.01±0.83	7.60±0.89	NS
	After	5.70±1.34	5.36±0.98	6.57±0.87	<0.001
CMAP	Before	4.17±0.42	4.98±0.76	4.49±0.42	NS
	After	4.17±0.44	5.78±1.58	4.46±0.41	NS
SNAP	Before	3.49±0.29	4.49±0.95	4.65±1.05	NS
	After	3.46±0.32	4.72±1.20	3.56±0.37	NS

VAS: Visual analogue scale; SSS: Symptom Severity Scale; FSS: Functional Status Scale; BCTQ: Boston carpal tunnel questionnaire; CMAP: Compound motor action potential; SNAP: Sensory nerve action potential; NS: Not significant.

^*p is two-sided significant.